Argenica Therapeutics Limited (ASX:AGN) Directors Insider Transactions



The Directors and Chief Executives of Argenica Therapeutics Limited (ASX:AGN) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Argenica Therapeutics Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Argenica Therapeutics Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Argenica Therapeutics Limited Directors/Insider Transactions Activity

List of Insider trades activity from Argenica Therapeutics Limited (AGN).

Date Director Director's Title Shares Value Note
12 Nov 2025 Budge (Terence Charles) Retired 805,702 - -
03 Jun 2025 Dallimore (Liz) Chief Executive Officer 352,345 - -
03 Mar 2025 Black (Robert) Former 25,000 - -
12 Nov 2024 McCall (Liddy) Former 443,182 - -
17 Sep 2024 Black (Robert) Director 25,000 - -
08 Aug 2024 Budge (Terence Charles) Director (Non-Executive) 318,182 - -
08 Aug 2024 Dallimore (Liz) Chief Executive Officer 1,590,909 - -
08 Aug 2024 McCall (Liddy) Director (Non-Executive) 318,182 - -
05 Jun 2024 Pocock (Geoffrey Richard) Non Executive Chairman 294,239 99,688 Exercise at price 0.34 per share.
05 Jun 2024 Pocock (Geoffrey Richard) Former 4,730,929 - -